Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a “non-druggable” target, STAT3 N-terminal domain
Pedro Andrade Bonilla(National Institutes of Health), Nadya I. Tarasova(National Institutes of Health)
Cited by 1
Related Papers
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
|Nature Communications|2024|19